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Introduction
Blepharophimosis–ptosis–epicanthus inversus syndrome
(BPES) (MIM#110100) is an autosomal dominant genetic
condition characterized by a complex eyelid malformation.
The main features of BPES are shortening of the horizon-
tal palpebral fissures (blepharophimosis), congenital ptosis,
telecanthus and epicanthus inversus, and variable expressiv-
ity of female infertility (premature ovarian failure) (POF) in
type I BPES while absent in type II (Zlotogora et al. 1983).
Both types of BPES are caused by mutations in the
FOXL2 gene (MIM# 605597), consisting of a single exon of
2.7 kb located on chromosome 3q23 (Crisponi et al. 2001).
It encodes a protein that belongs to the family of winged-
helix/forkhead transcription factors that contains 100 amino
acid DNA-binding forkhead domain and a polyalanine tract.
FOXL2 expression is restricted to developing eyelids of fetal
and adult ovarian granulosa cells (Cocquet et al. 2003).
In previous mutation studies intragenic mutations were
found in 70% of patients (De Baere et al. 2003). Recently, in
sporadic and familial BPES cases five microdeletions were
found outside the coding region of FOXL2. In addition, 11
rearrangements encompassing FOXL2 have been described.
Overall, genomic rearrangements encompassing or outside
the FOXL2 account for 16% of all molecular defects found
in BPES families (Beysen et al. 2005).
Genotype–phenotype correlations suggested that FOXL2
mutations resulting in predicted proteins with a truncation
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before the polyalanine tract might lead to development of
the POF (BPES type I). However, correlations for mutations
leading to a truncated or extended protein containing an in-
tact forkhead domain and polyalanine tract, and for missense
mutations in the highly conserved forkhead domain, are still
elusive. Large submicroscopic deletions may result in BPES
associated with mental retardation (De Baere et al. 2003;
Beysen et al. 2005).
Here we report the identification of intragenic FOXL2
mutations in two Indian families with BPES type I and II re-
spectively. We demonstrate that our results are in agreement
with previously reported genotype–phenotype correlations.
Materials and methods
Patients and clinical evaluation
Recruitment was based on interviews, questionnaires, and
clinical examination of aﬀected and unaﬀected individuals
by ophthalmologists. An informed consent was obtained in
compliance with the Helsinki Declaration. Clinical data are
shown in table 1. The pedigrees of the two families are
shown in figure 1a and figure 2a. A four-generation BPES
type I family with 14 aﬀected members of which nine are
alive, and were selected for genetic analysis (figure 1a). The
proband was a one-year-old girl with typical BPES and not
cooperative for visual acuity testing. However, adapted vi-
sual acuity testing revealed an acuity of atleast 6/24 or better.
Cycloplegic refraction revealed +0.5 D for the right eye and
+1.0 D for the left eye.
Keywords. BPES syndrome; FOXL2 gene; haploinsuﬃciency; premature ovarian failure (POF); FOXL2 polyalanine expansion; genetic
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Figure 1. a. Four-generation BPES type I pedigree. All aﬀected members have typical BPES. Three
aﬀected females from generations I and II are infertile. Aﬀected individual BPES III:1 has mental re-
tardation and microcephaly. The aﬀected and unaﬀected patients analysed molecularly are indicated
by numbers “IV:1, III:3, etc”. An asterisk indicates the two aﬀected individuals having mental retar-
dation and microcephaly. b. Sequence electropherogram showing the heterozygous FOXL2 mutation
c.273C > G (p.Y91X) found in aﬀected members of this BPES type I family. c. Segregation analysis in
aﬀected and unaﬀected family members using BseLI restriction enzyme digestion. The BseLI restric-
tion enzyme showed 175 bp and 113 bp in the wild type allele while additional fragments of 82 bp and
93 bp were observed in mutant alleles. These fragments were separated on a 2.5% agarose gel.
Another three-generation BPES type II family had three
aﬀected members, with a three-year-old male proband with a
typical BPES (figure 2a). Visual acuity recorded by Cardiﬀ
acuity chart and Teller preferential looking charts was 6/9 in
both eyes. The cycloplegic refraction was +1.0 D in both
eyes. The probands of both the families underwent frontalis
sling surgery in both the eyes for ptosis and Y-V plasty for
telecanthus correction.
Mutation analysis
Blood samples were collected from consenting individuals
followed by extraction of genomic DNA following a stan-
dard protocol. The coding region of the FOXL2 gene was
PCR amplified using previously reported primers (De Baere
et al. 2003; Kumar et al. 2004). The PCR amplicons were
sequenced bidirectionally (3730 ABIPRISM Analyzer, Big
Dye Terminator, Applied Biosystems) followed by RFLP
analysis. The segregation of the mutation in the BPES type
I family was assessed by restriction enzyme digestion us-
ing 2 units of BseLI (MBI FERMANTAS) followed by elec-
trophoresis on a 2.5% agarose gel (figure 1c).
Results and discussion
In a four-generation BPES type I family with nine living af-
fected members, three aﬀected females are infertile and two
aﬀected male patients (BPES III:1 and his younger brother)
have mental retardation with microcephaly (figure 1a). In
all the aﬀected individuals analysed a nonsense mutation
c.273C > G (p.Y91X) was identified in FOXL2, leading to
a predicted truncated protein of 90 amino acids (instead of
376) with a partial forkhead domain and polyalanine tract is
absent (figure 1b,c).
These mutations are supposed to lead to haploinsuﬃ-
ciency of FOXL2, since DNA-binding activity is abolished
due to disruption of the forkhead domain. Although in
general, transcripts with nonsense mutation are degraded
by nonsense-mediated decay (NMD), intronless genes as
the FOXL2 gene might escape NMD, giving rise to a
stable mutated transcripts and expressed mutated proteins
(Frischmeyer and Dietz 1999).
In general, mutations leading to the predicted proteins
with a partial forkhead domain are expected to lead to BPES
type I as suggested previously (De Baere et al. 2003). Indeed
this nonsense mutation leads to BPES type I in this family.
166 Journal of Genetics, Vol. 86, No. 2, August 2007
F0XL2 gene mutations
Ta
bl
e1
.C
lin
ic
al
fe
at
ur
es
of
In
di
an
fa
m
ili
es
w
ith
bl
ep
ha
ro
ph
im
os
is
-p
to
si
s-
ep
ic
an
th
us
in
ve
rs
us
sy
nd
ro
m
e.
B
PE
S
A
ﬀ
ec
te
d
A
ge
/S
ex
B
PE
S
IC
D
O
C
D
PF
L
(m
m
)
M
en
ta
l
M
ic
ro
ce
ph
al
y
In
fe
rt
ili
ty
C
on
sa
ng
ui
ni
ty
fa
m
ili
es
in
di
vi
du
al
s
(m
m
)
(m
m
)
R
E
L
E
re
ta
rd
at
io
n
Fo
ur
IV
:2
1/
F
+
33
74
3.
5
4
-
-
U
nk
no
w
n
-
ge
ne
ra
tio
n
II
I:
2
32
/M
+
35
88
3
3.
5
-
-
-
+
Ty
pe
1
II
I:
5
27
/M
+
N
M
N
M
N
M
N
M
-
-
-
+
(fi
gu
re
1)
I:
1
90
/F
+
36
92
4
6.
5
-
-
+
-
II
:1
68
/M
+
N
M
N
M
N
M
N
M
-
-
-
-
II
:2
65
/F
+
N
M
N
M
N
M
N
M
-
-
+
-
II
:4
62
/M
+
38
90
2
2
-
-
-
-
II
I:
1
40
/M
+
N
M
N
M
N
M
N
M
+
+
-
+
II
I:
6
10
/M
+
N
M
N
M
N
M
N
M
-
-
-
-
T
hr
ee
II
:1
53
/M
+
33
90
5.
5
5.
5
-
-
-
-
ge
ne
ra
tio
n
II
I:
1
27
/F
+
30
94
6.
5
6.
5
-
-
-
-
Ty
pe
II
IV
:1
3/
M
+
33
78
6
7
-
-
-
-
(fi
gu
re
2)
IC
D
,i
nn
er
ca
nt
ha
ld
is
ta
nc
e;
O
C
D
,o
ut
er
ca
nt
ha
ld
is
ta
nc
e;
PF
L
,p
al
pe
br
al
fis
su
re
le
ng
th
;B
E
,r
ig
ht
ey
e,
L
E
,l
ef
te
ye
;N
M
;n
ot
m
ea
su
re
d
“+
”,
Pr
es
en
t;
“-
”:
ab
se
nt
.
Figure 2. a. Three-generation BPES type II pedigree. The af-
fected and unaﬀected patients analysed at the molecular level are
indicated by numbers “II:1, III:1, etc”. b. Segregation analysis of
the 30-bp FOXL2 duplication c.672 701dup “g.909 938” using gel
electrophoresis on a 2.5% agarose gel, in aﬀected (heterozygous
PCR fragment of 304 bp and 334 bp) and unaﬀected family mem-
bers (homozygous fragment of 304 bp).
Interestingly, two aﬀected brothers have BPES with mental
retardation and microcephaly (figure 1a and table 1). The
younger brother died and could not be clinically examined
to undergo molecular testing; the older one however (BPES
III:1) was shown to carry the familial FOXL2 mutation. It
is not clear whether these associated features are caused by
the familial FOXL2 mutation in these brothers. Intragenic
FOXL2 mutations are known to occur in BPES individuals
with normal psychomotor development and normal head cir-
cumference (De Baere et al. 2003). It is important to men-
tion that these mentally retarded brothers descend from a
consanguineous marriage, their parents being first cousins.
Thus it cannot be excluded that the mental retardation and
microcephaly result from a diﬀerent recessive condition in-
dependent from BPES. Notably, one of the aﬀected females
(proband BPES IV:2) is a one-year-old female of whom the
BPES type cannot be assessed due to her prepubertal age (ta-
ble 1). However, she is predicted to develop BPES type I,
which has implications for genetic counseling.
In addition we identified a recurrent 30-bp duplication
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c.672 701dup “g.909 938” in the FOXL2 gene in a three-
generation family aﬀected by BPES type II (figure 2a). This
duplication cosegregated with the disease in this family (fig-
ure 2b). This mutation leads to an inframe polyalanine ex-
pansion in the FOXL2 protein (p.A224 A234 dup). It has
been reported as a pathogenic change in sporadic and fa-
milial cases in other ethnicities, but this is the first report
in an Indian pedigree with BPES (Human FOXL2 Mutation
Database; http://mebgen.ugenp.be/foxl2).
This polyalanine expansion represents more than 30% of
intragenic FOXL2 mutations. It is predicted to result in a hy-
pomorphic allele and lead to BPES type II. Recently, it was
proposed that the pathogenic mechanism of this polyalanine
expansion may be its mislocalisation (due to cytoplasmic ag-
gregation) together with its inclusion into nuclear aggregates
(Caburet et al. 2004). We have recently identified a short
homozygous polyalaline expansion (of 19 alalines instead of
14) in a consanguineous Indian pedigree, resulting in a reces-
sive form of BPES and ovarian dysfunction (Nallathambi et
al. 2007). The findings in our family lend further support to
the genotype–phenotype correlation for this type of mutation
(polyalanine expansion).
In summary, we have reported a nonsense mutation in
a BPES type I family and a recurrent duplication leading
to a polyalanine expansion in a BPES type II family, both
are of Indian origin. This is the first study where genotype–
phenotype correlations have been possible in Indian BPES
families. They are in agreement with previous mutation stud-
ies in BPES. Genotype–phenotype correlations in BPES are
especially useful for predictive testing of POF risk in aﬀected
females.
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